Effect of milnacipran on suicidality in patients with mild to moderate depressive disorder

Código QR

Effect of milnacipran on suicidality in patients with mild to moderate depressive disorder

Alla Avedisova, Vladimir Borodin, Ksenia Zakharova, Artem AldushinDepartment of Borderline Psychiatry, FGU State Scientific Research Center of Social and Forensic Psychiatry &ldquo;V.P. Serbsky&rdquo;, Moscow, RussiaAbstract: The presence of suicidal manifestations (thoughts and beha...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Alla Avedisova, Vladimir Borodin, Ksenia Zakharova, et al
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2009
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/770cdf6531134993afdd04e67a378670
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Suicidality: risk factors and the effects of antidepressants. The example of parallel reduction of suicidality and other depressive symptoms during treatment with the SNRI, milnacipran
por: Philippe Courtet
Publicado: (2010)

Milnacipran: recent findings in depression
por: Guest editors: Stuart Montgomery (London, et al.
Publicado: (2010)

Milnacipran and venlafaxine at flexible doses (up to 200 mg/day) in the outpatient treatment of adults with moderate-to-severe major depressive disorder: a 24-week randomized, double-blind exploratory study
por: Jean-Pierre Oli&eacute;, et al.
Publicado: (2010)

Editorial Foreword - Milnacipran: recent findings in depression
por: Stuart Montgomery, et al.
Publicado: (2010)

Suicide risk in depression and bipolar disorder: Do impulsiveness-aggressiveness and pharmacotherapy predict suicidal intent?
por: Maurizio Pompili, et al.
Publicado: (2008)

Rapid improvement of depressive symptoms in suicide attempters following treatment with milnacipran and tricyclic antidepressants &ndash; a case series
por: Kirino E, et al.
Publicado: (2011)

Treatment of patients with comorbid depression and diabetes with metformin and milnacipran
por: Peter Hofmann
Publicado: (2010)

Double-blind, comparative study of milnacipran and paroxetine in Japanese patients with major depression
por: Kamijima K, et al.
Publicado: (2013)

Double-blind, comparative study of milnacipran and paroxetine in Japanese patients with major depression [Corrigendum]
por: Kamijima K, et al.
Publicado: (2013)

Influence of serotonergic/noradrenergic gene polymorphisms on nausea and sweating induced by milnacipran in the treatment of depression
por: Hisashi Higuchi,&nbsp;Hitoshi Takahashi, et al.
Publicado: (2009)

Antidepressant therapy with milnacipran and venlafaxine
por: Lucilla Mansuy
Publicado: (2010)

Milnacipran: a unique antidepressant?
por: Siegfried Kasper, et al.
Publicado: (2010)

Neurochemical metabolites in prefrontal cortex in patients with mild/moderate levels in first-episode depression
por: Sozeri-Varma G, et al.
Publicado: (2013)

Role and rationale for the use of milnacipran in the management of fibromyalgia
por: Jay D Kranzler, et al.
Publicado: (2010)

Usefulness of milnacipran in treating phantom limb pain
por: Matsumoto Y, et al.
Publicado: (2012)

Improvement of the noradrenergic symptom cluster following treatment with milnacipran
por: Kasper S, et al.
Publicado: (2011)

&nbsp;Diabetes mellitus and comorbid depression: improvement of both diseases with milnacipran. A replication study (results of the Austrian Major Depression Diabetes Mellitus study group)
por: Abrahamian H, et al.
Publicado: (2012)

Increased mRNA expression of cytochrome oxidase in dorsal raphe nucleus of depressive suicide victims
por: A Sanchez-Bahillo, et al.
Publicado: (2008)

Persistent suicide risk in clinically improved schizophrenia patients: challenge of the suicidal dimension
por: Amresh Shrivastava, et al.
Publicado: (2010)

Effects of milnacipran on binge eating &ndash; a pilot study
por: Shun&rsquo;ichi Noma, et al.
Publicado: (2008)

Diabetes mellitus and co-morbid depression: treatment with milnacipran results in significant improvement of both diseases (results from the Austrian MDDM study group)
por: Heidemarie Abrahamian, et al.
Publicado: (2009)

Brain-derived neurotrophic factor: role in depression and suicide
por: Yogesh Dwivedi
Publicado: (2009)

Getting the balance right: Established and emerging therapies for major depressive disorders
por: Bojana Perovic, et al.
Publicado: (2010)

Agomelatine in the treatment of mild-to-moderate depression in patients with cardiovascular disease: results of the national multicenter observational study PULSE
por: Medvedev VE
Publicado: (2017)

Retrospective case studies of the efficacy of caprylic triglyceride in mild-to-moderate Alzheimer's disease
por: Maynard SD, et al.
Publicado: (2013)

Comparative efficacy and safety of Crocus sativus L. for treating mild to moderate major depressive disorder in adults: a meta-analysis of randomized controlled trials
por: Yang XY, et al.
Publicado: (2018)

Psychiatric comorbidity and suicide risk in patients with chronic migraine
por: Maurizio Pompili, et al.
Publicado: (2010)

Retrospective cohort study of the efficacy of caprylic triglyceride in patients with mild-to-moderate Alzheimer's disease
por: Maynard SD, et al.
Publicado: (2013)

Epilepsy and suicide: pathogenesis, risk factors, and prevention
por: Alberto Verrotti, et al.
Publicado: (2008)

Effect of triiodothyronine (T3) augmentation of acute milnacipran administration on monoamine levels: an in vivo microdialysis study in rats
por: Kitaichi Y, et al.
Publicado: (2012)

Depressive and adjustment disorders &ndash; some questions about the differential diagnosis: case studies
por: A Presicci, et al.
Publicado: (2010)

Correction to: Rasch analysis of the Brain Injury Screening Tool (BIST) in mild traumatic brain injury
por: Nusratnaaz Shaikh, et al.
Publicado: (2021)

Correction to: Exposure to mild blast forces induces neuropathological effects, neurophysiological deficits and biochemical changes
por: Adan Hernandez, et al.
Publicado: (2021)

Correlates of current suicide risk among Thai patients with bipolar I disorder: findings from the Thai Bipolar Disorder Registry
por: Suttajit S, et al.
Publicado: (2013)

A preliminary assessment of a combination of rhodiola and saffron in the management of mild–moderate depression
por: Bangratz M, et al.
Publicado: (2018)

Desvenlafaxine in the treatment of major depressive disorder
por: Maria Teresa C Lourenco1, et al.
Publicado: (2009)

Movement Disorders Associated with COVID-19
por: Mehri Salari, et al.
Publicado: (2021)

Psychiatric comorbidities in patients with major depressive disorder
por: Thaipisuttikul P, et al.
Publicado: (2014)

Comorbid personality disorders among patients with depression
por: Wongpakaran N, et al.
Publicado: (2015)

Increase in IL-6 levels among major depressive disorder patients after a 6-week treatment with duloxetine 60 mg/day: a preliminary observation
por: Michele Fornaro, et al.
Publicado: (2011)